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Background: Ayurveda, the traditional Indian system of medicine has given great emphasis to the promotion of
health. Rasayana is one of the eight branches of Ayurveda which refers to rejuvenant therapy. It has been reported
that rasayanas have immuno-modulatory, antioxidant and antitumor functions, however, the genotoxic potential
and modulation of DNA repair of many rasayanas have not been evaluated.
Methods: The present study assessed the role of Brahmarasayana (BR) on Ethyl methanesulfonate (EMS)-and Methyl
methanesulfonate (MMS)-induced genotoxicity and DNA repair in in vivo mouse test system. The mice were orally
fed with BR (5 g or 8 mg / day) for two months and 24 h later EMS or MMS was given intraperitoneally. The
genotoxicity was analyzed by chromosomal aberrations, sperm count, and sperm abnormalities.
Results: The results have revealed that BR did not induce significant chromosomal aberrations when compared to
that of the control animals (p >0.05). On the other hand, the frequencies of chromosomal aberrations induced by
EMS (240 mg / kg body weight) or MMS (125 mg / kg body weight) were significantly higher (p<0.05) to that of
the control group. The treatment of BR for 60 days and single dose of EMS or MMS on day 61, resulted in
significant (p <0.05) reduction in the frequency of chromosomal aberrations in comparison to EMS or MMS
treatment alone, indicating a protective effect of BR. Constitutive base excision repair capacity was also increased in
BR treated animals.
Conclusion: The effect of BR, as it relates to antioxidant activity was not evident in liver tissue however rasayana
treatment was observed to increase constitutive DNA base excision repair and reduce clastogenicity. Whilst, the
molecular mechanisms of such repair need further exploration, this is the first report to demonstrate these effects
and provides further evidence for the role of brahmarasayana in the possible improvement of quality of life.
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It is well known that traditional systems of medicines
are playing an important role in global health care needs.
India is one of the most medico-culturally diverse coun-
tries in the world where Ayurveda, Yoga, Unani, Siddha
and other forms of traditional practice have been the
mainstay to maintain human health and prevent diseases
until the era of modern medicine. In addition to these
systems, there are large numbers of folklore healers in
this stream who have not been structured under these
categories. Among these traditional medicinal systems,
Ayurveda is the holistic, comprehensive ancient medical
science practiced in India since the 12th Century B.C.
The Ayurvedic therapeutic modality comprises eight
angas or chikitsas, each defining a specific branch of study.
Rasayana chikista (also known as Jarachikitsa) encompasses
the treatment of ageing through rejuvenation. The en-
hancement of Rasa (essence) is the quintessential quality
that all Rasayana medicines possess, ultimately helping to
promote health and vigour of the tissues in the body [1].
They have a characteristic tendency to improve the nutri-
tional status of the body and alleviate symptoms of stress
through three basic mechanisms - Rasa (nutrient effect),
Agni (digestion and metabolism) and Srotas (microcircula-
tion and tissue perfusion) [2]. All Rasayanas are unique for-
mulations of a number of plants, herbs and spices. There
are certain organ and tissue specific Rasayanas such as
Medhya rasayana for the brain, Hridya rasayana for the
heart, Twachya rasayana for the skin and Chakshusya
rasayana for the eyes. Similarly, they may be age specific as
they promote nutrition relevant to natural bio-losses occur-
ring at different phases of human life [2]. Rasayana drugs
are rich in antioxidants and are good hepato-protective [1]
and immunomodulating [3] agents.
Brahmarasayana is one such Medhya rasayana com-
prising of more than 35 ingredients of which the plants
Emblica officinalis (Goose berry) and Terminalia che-
bula (Indian Gall nut) are the two major. It is reported
to retard brain ageing and help in regeneration of neural
tissues with anti stress, adaptogenic and memory enhan-
cing effects [2]. BR has often shown to be a potent anti-
oxidant and free radical scavenger in mice [4], heat
stressed chicken [5] and cold stressed chicken [6]. BR
has also been investigated as an anti-cancer agent, redu-
cing the mass and incidence of palpable tumours in
adult malignant rat prostrate tumor cell (MAT-LyLu)
inoculated Copenhagen rats [7] and repressing the pro-
duction of pro-angiogenic factors like vascular endothe-
lial growth factor (VEGF), matrix metalloproteinase 9
(MMP-9) and matrix metalloproteinase 2 (MMP-2) [8].
It has been also observed that BR does not elicit any
genotoxic effects. Instead it was shown to increase the
mitotic cellularity and altogether alleviate certain types
of normally occurring sperm abnormalities [9].It is well known that the genome of all the organisms
including human is susceptible to damages caused by
vast array of both endogenous and exogenous DNA
damaging agents. Repair of such DNA damages play an
important role in cellular functions. Defects in DNA re-
pair or inefficiency of DNA repair machinery results in
accumulation of DNA damages in the genome which in
turn are responsible for various disorders including can-
cer and ageing. Although various beneficial effects of
Brahmarasayana were investigated, there are no reports
to date of BR on potentiation or protection of DNA re-
pair. Hence, the present study was undertaken to evalu-
ate the effect of BR on chromosomal aberrations
induced by ethyl methanesulfonate (EMS) and methyl
methanesulfonate (MMS), two well-known mutagenic
and clastogenic agents in in vivo mouse test system. Fur-
thermore, the effect of BR on constitutive base excision
repair has also been undertaken to understand its role as
a repair enhancer.Methods
Animals
Inbred male Swiss albino mice (Mus musculus), 6–
8 weeks old and weighing about 30–40 g were used in
all experiments. Animals were obtained from the De-
partmental Animal House. They were maintained in
polypropylene shoebox cages with a grill top. Paddy husk
was used as bedding material and the animals were fed
with standard diet and water ad libitum. Three animals
were housed per cage and utmost care was taken to
maintain cage hygiene and also provide good ventilation
and aeration in the room where the animals were
housed. The study was approved by the Institutional ani-
mal ethics committee (Kasturba Medical College, Mani-
pal) and all experiments were performed in accordance
with the guidelines of the ethics committee. Bone mar-
row cytogenetic assay was employed to determine any
clastogenic effects in dividing cells.Chemicals
Brahmarasayana a commercially available product pre-
pared by Arya Vaidya Sala (Kotakkal, India) was pur-
chased from local Ayurvedic vendors. The manufacture
and expiry date of each batch (Batch Nos. 501003,
503232, 503539, 503772 and 504015) was noted. In
addition, the HPTLC profile of batch specific product
was obtained from the manufacturer and placed on rec-
ord for authentication and comparison purposes. These
data are available upon request. Ethyl methanesulfonate
(EMS) (CAS No. 62-50-0) and Methyl methanesulfonate
(MMS) (CAS No. 66-27-3) served as standard clastogens
and were purchased from Sigma Aldrich (St. Louis,
USA).
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Brahmarasayana was administered in two different
doses. The dose, based on body surface area of mice,
was prepared in the form of food pellets, wherein 5 g of
BR was mixed with 5 g of animal feed (henceforth
known as Rasayana1). This mixture was then pressed
into pellets which, upon drying for a few hours, became
hard and was ideal for chewing. The second dose, based
on a body weight of 250 mg/kg body weight/day, was
prepared by mixing approximately 8 mg of BR with ster-
ile water (0.5 mL) and administering by gavage (hence-
forth known as Rasayana 2). Two different groups of
animals were fed daily for 60 days with either Rasayana
1 or Rasayana 2.
EMS and MMS administration
Sub-lethal high doses of EMS (240 mg/kg body weight)
and MMS (125 mg/kg body weight) were employed (one
day after rasayana treatment), as earlier established by
Riaz Mahmood and Vasudev [10]. The required volumes
of EMS and MMS were dissolved in 0.9% NaCl and the
solution (0.5 mL) administered intraperitoneally (i.p.).
Treatment schedule
Control
Mice were provided with regular food. On day 61, these
animals received 0.9% NaCl solution (0.5 mL) as intra-
peritoneal (i.p.) injection.
Rasayana
Two groups of animals were fed BR at the level of 5 g /
day (Rasayana 1: n = 9) and 8 mg /day (Rasayana 2:
n = 9) for 60 days. On day 61, these animals received
0.9% NaCl solution (0.5 mL) by i.p. injection.
Clastogen treatment
Animals were divided into two groups and maintained
for 60 days with regular food. On day 61, one of the
groups (n = 9) were injected with EMS (240 mg/kg body
weight) whilst the other group (n = 9) with MMS
(125 mg/kg body weight).
Rasayana and EMS-or MMS-combined treatment
Two groups of animals (n = 9 for each group) were fed
with Rasayana 1 (Group 1) and Rasayana 2 (Group 2)
for 60 days. After 60 days, one group of animals belong-
ing to Rasayana 1 and Rasayana 2 were injected with
EMS and the other group with MMS at the same dose
as injected for the clastogen treatment group alone.
Mitotic preparation and chromosome analysis
Animals were sacrificed at 24 h, 48 h and 72 h after the
treatment of clastogen or 0.9% NaCl by i.p. injection.
Colchicine (0.05% : 0.5 mL), a spindle fibre inhibitor thatarrests cells at metaphase was also administered by i.p.
injection 90 minutes prior to sacrifice of these animals.
These animals were sacrificed by cervical dislocation and
bone marrow cytogenetic assay was employed to deter-
mine any clastogenic effects in dividing cells. The bone
marrow was processed and slides were prepared by rou-
tine standard air dry technique [11]. In brief, the femur
bones were dissected and flushed with 0.56% KCl (5 mL)
with the help of a 26 gauge needle attached to a syringe
(5 mL). The suspension was then incubated at 37°C for
15 to 20 minutes. After incubation, the tubes were cen-
trifuged at 3000 rpm for 10 minutes at 4°C. The super-
natant was discarded and cold Carnoy’s fixative (3:1 v/v
of methanol: acetic acid, 5 mL) was added and mixed in-
tensively to avoid clumping of cells. The tubes were kept
at room temperature for 30 minutes and once again cen-
trifuged for another 10 minutes at 4°C (3000 rpm) and
the supernatant removed. This process was repeated
twice over 20 minute intervals. Finally the pellet was
resuspended in Carnoy’s fixative (0.5 mL) and dropped
from a height on a non-greasy chilled glass slide using a
fine tipped pasteur pipette. The slides were air-dried,
coded and stained with 4% Giemsa for 20–30 minutes.
The stained slides were rinsed thoroughly with running
tap water followed by distilled water and dried before
being viewed under the microscope. Chromosomal aber-
rations such as chromatid breaks, chromatid exchanges,
intra-chromatid deletions, triradials, chromosome
breaks, dicentrics, rings, minutes and RB complexes
were scored. In each treatment schedule, a minimum of
600 well spread, non-overlapping metaphase plates were
scored.
Evaluation of Mitotic Index (MI)
Mitotic Index was analysed in order to understand the
effect of BR on cell proliferation in different treatment
schedules. To analyze the rate of mitosis, the numbers
of mitotic cells in a total of at least 2000 cells were
scored for each treatment schedule. The Mitotic index
was calculated by using the formula below.
%MI
¼ Number of cells in mitosisTotal number of cells scored
h i
 100
Base excision repair assay
Approximately 1 g of liver from control, Rasayana 1 and
Rasayana 2 groups of mice was homogenized with PBS
(pH= 7.4, 10 mL) immediately after the sacrifice to ob-
tain a 10% homogenate. The homogenate was then cen-
trifuged at 3000 rpm for 10 minutes at 4°C to obtain a
pellet of cells. Whole cell protein extract was prepared
by following standard method. Protein content was
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centration of protein was mixed with Cy3-labeled DNA
duplex with one gap. The reaction mix was incubated
for 90 minutes at 37°C. After incubation, formamide
(20 μL) was added to the sample to stop the reaction
and the tubes were kept in boiling water (90°C) for 10
minutes. Tubes were snap cooled in ice for 2 minutes
after which the sample and dye were loaded on to 7 M
urea gel. The gel was run for 2 hours at 250 V and
scanned with Phosphor-imager and analyzed.
Antioxidant analyses
Rasayanas are potent antioxidants which may have a role
in DNA repair. In this regard, BR was also evaluated for
its antioxidant activities in mouse test system. The dif-
ferent antioxidant enzymes such as Superoxide dismu-
tase (SOD) [13], Catalase [14], Glutathione S transferase
(GST) [15] and GSH [16] were analyzed using the liver
tissue of the treated and control animals.
Reproductive toxicity
Reproductive toxicity was analyzed by sperm count and
sperm shape abnormalities. Sperm counts were carried
out by following the method of Searle and Beechey [17].
Paired capita were macerated in 1–2 mL of 1% (w/v) tri-
sodium citrate and the resulting suspension was further
diluted to 4 mL. After mixing, the spermatozoa were
counted using an improved Neubauer haemocytometer.
The suspension was mixed with 1% Eosin Y in a 10:1
ratio for the analysis of sperm shape abnormalities [9].
The mixture was allowed to stand for 30 minutes and
slides were prepared. These slides were air dried and
examined by microscopy for the presence of various
sperm shape abnormalities. A minimum of 2000 sperms
were counted per animal.
Statistical analysis
The data are expressed as mean ± SEM. Statistical sig-
nificance was assessed using Student’s t test. Differences
were considered as statistically significant at p <0.05.
Results
The present study addressed the effect of BR on DNA
repair and EMS or MMS-induced chromosomal aberra-
tions in in vivo mouse test system. The results obtained
after BR treatment are presented in Figure 1 where it is
evident that BR treatment alone did not induce signifi-
cant chromosomal aberrations when compared to that
of the control animals (p >0.05). The chromosomal aber-
rations induced by ethyl methanesulfonate (EMS;
240 mg / kg body weight; positive control) were signifi-
cant (p <0.05) to that of the control group (Figure 1A).
The frequency of breaks per cell in the EMS treated
group at 24 h was 0.46 ± 0.019, which was significantlyhigher when compared to that of total number of breaks
per cell in the control group (0.013 ± 0.003) (p <0.05).
Similar results were also observed at 48 h (0.36 ± 0.001)
and 72 h (0. 24 ± 0.014) which were significantly higher
than the control and BR only treated groups
(Figure 1A). The frequencies of chromosomal aberra-
tions induced by methyl methanesulfonate (MMS; posi-
tive control) was also significantly higher when
compared to controls at all recovery times tested
(Figure 1B). The chromosomal aberrations induced by
EMS and MMS are mainly chromatid breaks, exchanges,
intra chromatid deletions and minutes at all the recovery
times tested.
Our results also showed that in the BR and EMS com-
bined treatment group, the frequency of chromosomal
aberrations was significantly lower (0.27 ± 0.018 for
rasayana 1 and 0.30 ± 0.01 for rasayana 2) in comparison
to those observed for the EMS only treated group at
24 h. Similar results were observed at 48 h and 72 h re-
spectively (Figure 1A). On par with this, BR and MMS
combined treatments also showed a significant reduction
in the frequency of chromosomal aberrations at all the
recovery times tested (Figure 1B). This is the first of this
kind to our knowledge where BR is observed to reduce
the clastogenic effects of two well-known alkylating
agents viz., EMS and MMS.
Data of mitotic analysis showed that there was reduced
number of cells in mitosis in EMS-and MMS-treated
groups at 24, 48 and 72 h (Table 1). On the other hand,
there was an increase in the number of mitotic cells in
animals treated with Rasayana 1 (human equivalent dose
calculated based on body surface area) at 24 h. The
number of mitotic cells in all the other treatment groups
was almost similar to that of controls indicating there is
no mitotic selection.
Reproductive toxicity of BR was evaluated by employ-
ing Sperm count and Sperm abnormality assays. The
results have shown that there was no variation in the
number of sperms in rasayana treated animals when
compared to control animals (Table 2). In addition, the
analyzed sperm shape abnormalities were also found to
be insignificant to that of sperm shape abnormalities in
the control group indicating that BR is not inducing re-
productive toxicity in the mice (Table 2).
Constitutive base excision repair capacity was tested in
BR-treated and control animals by employing cell free
liver extracts. It is interesting to note that there was
increased repair in BR-treated animals when compared
to controls (Figure 2) indicating enhancement of DNA
base excision repair.
Rasayanas are potent antioxidants which may have a
role in DNA repair. In this direction, BR was also evalu-
ated for its antioxidant activities. The results have
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Figure 1 Chromosome breaks per cell in rasayana and A) EMS- B). MMS-treated mouse bone marrow cells at different recovery times. EMS
or MMS alone (positive controls) elicited high frequencies of breaks per cells whereas the animals without any treatment (negative controls)
showed very less frequencies of breaks per cells. Rasayana 1 and 2 produced insignificant (p >0.05) breaks per cell compared to controls. The
combined treatments of Rasayana1 and EMS; Rasayana 2 and EMS or Rasayana 1 and MMS; Rasayana 2 and MMS showed significant (p <0.05)
reduction in the frequencies of breaks per cell at 24 h, 48 h and 72 h recovery times.
Table 1 Mitotic Indices in mouse bone marrow cells of
Brahmarasayana and EMS- or MMS- treated groups at
different recovery times
Treatment Groups 24 h 48 h 72 h
Control 4.70 ± 0.06 4.50 ± 0.28 4.22 ± 0.23
Rasayana I (BSA) 7.40 ± 1.42 4.53 ± 0.63 5.66 ± 0.89
Rasayana II (B.W.) 4.20 ± 0.30 4.06 ± 0.37 4.10 ± 0.05
EMS 2.10 ± 0.17* 2.46 ± 0.08* 2.05 ± 0.12*
Rasayana I +EMS 4.52 ± 0.11 4.03 ± 0.12 4.06 ± 0.14
Rasayana II +EMS 3.06 ± 0.35 3.06 ± 0.08 3.23 ± 0.20
MMS 3.50 ± 0.06 3.54 ± 0.15 3.74 ± 0.15
Rasayana I+ MMS 5.52 ± 0.19 5.62 ± 0.15 5.40 ± 0.15
Rasayana II + MMS 4.62 ± 0.10 4.01 ± 0.11 5.20 ± 0.12
*Significant when compared to control animals (p <0.05).
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pared to the controls. The groups receiving BR and EMS
combination treatments showed maximum SOD activity
when compared to all other treated groups of animals
suggesting antioxidant activity of BR (Table 3). Catalase
activities were reduced in combined treatment of BRTable 2 Sperm count and Sperm abnormalities in
Brahmarasayana-treated animals




Control 4.40 ± 0.46 2.57 ± 0.45
Rasayana I (BSA) 4.85 ± 0.29 2.60 ± 0.25






























Figure 2 Constitutive base excision repair in BR-treated animals
after 24 h recovery time. Constitutive repair in Rasayana 1 and
Rasayana 2 treated animals are significantly (p <0.05) higher
compared to control animals.
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ever in case of MMS treatment, combined treatment of
rasayana 1 and MMS showed higher levels of catalase
activity in comparison to MMS only. This may be the re-
sult of differential action of EMS and MMS. The data
also indicate that in the Rasayana 2, EMS- and MMS-
treated animals show little GST activity when compared
to other treatment regimens. On the other hand, there
was no significant variation in GSH levels in all the
treatment groups (Table 3).
Discussion
It is beyond doubt that DNA is the primary target of
several chemicals and physical agents which cause the
genetic alterations viz. point mutations, chromosomal
aberrations, sister chromatid exchanges (SCEs) and
others. These induced alterations in the DNA, if accu-
mulated leads to various health hazards including can-
cer. However, there are several mechanisms to repair the
damaged DNA in the living organisms, which are re-
sponsible to maintain the stability of genetic material.Table 3 Anti-oxidant levels in BR- and EMS- or MMS- treated
Treatment Group SOD Activity / mg protein Catalase Activity / m
Control 0.02 ± 0.01 5.32 ± 1.09
Rasayana I 0.03 ± 0.01 7.69 ± 2.85
Rasayana II 0.01 ± 0.01 5.13 ±0.13
EMS only 0.03 ± 0.01 10.73 ± 2.31
Rasayana I + EMS 0.04 ± 0.01* 4.09 ± 0.55
Rasayana II + EMS 0.05 ± 0.01* 4.59 ± 0.16
MMS Only 0.02 ± 0.01 2.68 ± 1.16
Rasayana I + MMS 0.05 ± 0.00* 6.17 ± 1.29
Rasayana II + MMS 0.04 ± 0.01* 3.80 ± 1.23
* Significant when compared to animals treated with EMS or MMS only (p <0.05).
**Significant when compared to Control animals (p <0.05).Defective or inefficient repair machinery may not com-
bat efficiently the genotoxic effects induced by the
agents. Furthermore, the efficiency of DNA repair ma-
chinery may also be comparable to rate of repair /
removal of DNA damages. Therefore, we hypothesize
that the DNA repair efficiency may be modulated by
rasayanas. Hence, in the present investigation, an at-
tempt was made to understand the effect of Brahmara-
sayana, a well-known Medhya rasayana on EMS- and
MMS- induced chromosomal aberrations / repair of
chromosomal aberrations in an in vivo mice system.
Two different doses of BR, one based on body surface
area extrapolated from the Human Equivalent Dose
(HED) [18] and another based on the body weight of
animals (which is equivalent to the human dose admi-
nistered by Ayurveda doctors to the patients) were
employed to overcome the discrepancies with respect to
several parameters in mammalian species [18]. Further,
in Ayurveda rasayanas are generally administrated for
longer duration. Hence, in the present study, animals
were treated for 60 days. The results of the present stud-
ies have clearly shown that the treatment of BR, elicited
insignificant (p >0.05) number of breaks per cell when
compared to that of breaks observed in control animals,
as observed in the earlier study [9], indicating no geno-
toxicity of BR. On the other hand, significantly higher
frequencies (p <0.05) of chromosomal aberrations were
induced by positive controls such as EMS and MMS.
Furthermore, it was observed that the chromosomal
aberrations induced by EMS and MMS were mainly
chromatid breaks, exchanges, intrachromatid deletions
and minutes at all the time points tested. These results
were similar to the earlier observations [10,19-22]. EMS
and MMS are both alkylating agents, electrophilic com-
pounds, with the ability to attack the nucleophilic cen-
tres of DNA and capable of inducing a variety of lesions
including DNA adducts, cross-links and strand breaks,
which can be expressed as chromosomal aberrations. Itanimals
g protein GSH activity / mg protein GST activity / mg protein
2.44 ± 0.53 8.26 ± 1.32
2.15 ± 0.28 7.11 ± 2.68**
2.66 ± 0.02 1.46 ± 0.09**
** 1.55 ± 0.79** 2.09 ± 0.90**
2.75 ± 0.00 6.94 ± 2.54
2.48 ± 0.09 11.47 ± 6.36
** 2.83 ± 0.07 0.72 ± 0.18**
* 1.81 ± 0.66 8.92 ± 5.17
2.48 ± 0.28 9.91 ± 2.44
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reduction in the frequency of chromosomal aberrations
induced by EMS or MMS in animals pre-treated with
BR (Figure 1) indicating either prevention of EMS
induced chromosomal damage or enhancement of DNA
repair by BR. The differences between MMS and EMS-
induced breaks can be explained either by differences in
the patterns of alkylation by the two compounds (e.g.,
the amount of N3-alkyladenine versus the amount of
O6-alkylguanine) or by differences in the way in which
cells process the respective adduct(s). There are different
mechanisms which lead to chromosomal aberrations
such as mis-repairing of double strand breaks [23],
stickiness and direct breakage of phosphor di-ester
bonds of DNA by alkylating agents [24] and others
which rely on DNA damaging agents; and free radical
generation and DNA damage is one such mechanisms.
The future work needs to be focused on unravelling the
mechanistic pattern of cellular damage with respect to
free radicals and alkylating agent-induced chromosomal
damage. Furthermore, this is the first of this kind to our
knowledge where BR is reducing clastogenic effects of
two well-known alkylating agents viz., EMS and MMS.
Consistent with this, Sharma et al. [25] have shown that
Emblica officinalis plant extract, one of BR’s principal
ingredients, has an inhibitory effect on mutagen-induced
chromosomal anomalies in Swiss albino mice. Oral ad-
ministration of plant extract (250 and 500 mg/kg body
weight) for 7 days together with single doses of the
mutagens, Benzo (a) pyrene (125 mg/kg body weight) or
cyclophosphamide (40 mg/kg body weight intraperito-
nially), significantly reduced frequencies of chromosomal
aberrations and micronuclei in Swiss albino mice were
observed compared to treatment with mutagens alone.
Administration of rasayana namely Chyavanaprasha (5,
7.5,10,15, 20, 40 and 80 mg/kg body weight) for 5 con-
secutive days and treatment later with 10 Gy of gamma-
rays also showed an alleviation in symptoms of radiation
sickness like reduction in food and water intake, irrit-
ability, weight loss, emaciation, lethargy, diarrhea and fa-
cial edema. There was also a delay in mortality of
animals indicating radioprotective activity of Chyavana-
prasha [26]. Another rasayana viz., Triphala also showed
radioprotection in mice [27]. The in vivo treatment with
Triphala (oral: 40 mg/ kg body weight) on mice trans-
planted with mouse thymic lymphoma (barcl-95) cells
produced significant reduction in tumor growth. Tri-
phala was shown to induce cytotoxicity in tumor cells
but not in normal cells and appears to be related to its
ability to evoke differential response in intracellular ROS
generation [28]. Similar anti mutagenic activity of Tri-
phala was observed in 115 (S115) and MCF-7 breast
cancer cells as well as PC-3 and DU-145 prostate cancer
cells [29]. Joshi and Parle [30] have treated mice withdifferent concentrations of Brahmi rasayana and
demonstrated that the high dose of Brahmi rasayana
(200 mg/kg) elicited improved memory and learning in
mice when compared to mice treated with scopolamine.
Further, pre-treatment with Brahmi rasayana for 8 days
protected both young and old mice against scopolamine-
induced amnesia.
In the present investigations, constitutive base excision
repair capacity was also tested in BR treated and control
animals in support of protective activity of BR, by
employing cell free liver extracts. It is interesting to note
that there was increased repair in BR treated animals in
comparison to controls (Figure 2) indicating enhance-
ment of DNA base excision repair. This may be related
to the increased ability of the repair machinery or
amount of the enzymes in the cells, which needs to be
addressed in future. We did not assess the BER capacity
in EMS and MMS-challenged animals or animals treated
with BR and EMS or MMS-combined treatments as they
already possess inherently high levels of DNA damage
and repair and it is difficult to discern differences in BR-
treated and clastogen only-treated groups.
Data of Mitotic analysis showed that there was reduced
number of cells in mitosis in EMS and MMS-treated
groups at 24, 48 and 72 h (Table 1). This is understandable
as cells with a large number of breaks stop cell cycle. How-
ever, there was an increase in the number of mitotic cells in
animals treated with Rasayana 1 (human equivalent dose
calculated based on body surface area) at 24 h whilst the
number of mitotic cells in all the other treatment groups
was almost similar to that of controls indicating there is no
mitotic selection. This particular finding validates the use of
two dosing regimens. We find that Rasayana 1, in addition
to being more protective, also induces greater mitotic cellu-
larity. Utilizing human equivalent doses (as in Rasayana 1)
of Ayurvedic formulations for animal studies present a
more realistic outcome in terms of translation and by this
notion BR elicits better protection, at least in the mice trea-
ted with Rasayana 1. On a par, BR treated irradiated mice,
showed increase in total leucocyte count and bone-marrow
cellularity [31]. Kumar et al [32] have reported the
immuno-stimulatory property of BR in mice. It enhanced
proliferation of spleen cells, increased the activity of ester-
ase and humoral immune response. Administration of BR
to cancer patients undergoing radiotherapy also resulted in
the recovery of haematopoetic system, as shown by
increased levels of neutrophils and lymphocytes, reduction
of leucopenia, neutropenia and lymphopenia [33]. Further-
more, cancer chemotherapy with cyclophosphamide results
in myeolosuppression and BR found to reduce myelosup-
pression and subsequent leucopenia [34].
Reproductive toxicity of BR was analyzed by employ-
ing Sperm count and Sperm abnormality assays. The
results have shown that there was no variation in the
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pared to control animals (Table 2). In addition the ana-
lyzed sperm shape abnormalities were also found to be
insignificant to that of sperm shape abnormalities in
control animals indicating BR is not inducing reproduct-
ive toxicity in the mice (Table 2). These results are in ac-
cordance with our earlier findings [9].
Rasayanas are potent antioxidants which may have a
role in DNA repair. In this regard, BR was also evaluated
for its antioxidant activities in mouse test system. Assays
evaluating the SOD, catalase, GST and GSH activities in
the control and other experimental groups have revealed
marginal differences as indicated in Table 3. Whilst cited
studies do reveal antioxidant potential of rasayana, the
assessment through the various enzymes could also be
organ specific. Singh et al. [35] evaluated the plant
Tinospora cordifolia against oxidative stress on Swiss
albino mice and found that SOD, catalase and GST
levels were significantly increased in the lung whilst in
the kidney, only catalase and SOD were increased at
both dose levels of treatment given. However, Rekha et
al [4,36] have shown that BR treatment resulted in
increased levels of SOD and catalase in irradiated mice.
Rekha et al [37] also examined free oxygen radical scav-
enging activity of BR in both in vivo and in vitro test sys-
tems and found that the lipid peroxides, hydroxyl
radicals, superoxides, nitric oxide and nitrite production
were reduced by BR indicating antioxidant effect of BR.
Male chickens treated with BR (2 g/ kg body weight) for
10 days and heat stressed (40 ± 1°C for 5 or 10 days)
showed enhanced action of enzymatic and non-
enzymatic antioxidants and also nullified the effects of
free radicals generated during heat stress. Further, they
observed significant increase in the haemoglobin content
in these BR treated and heat-stressed birds compared to
birds subjected to heat-stress alone. In addition the lipid
peroxidation level was significantly higher in heat
stressed birds. However the administration of BR to the
stressed animal showed reduction in the lipid peroxida-
tion and this was brought back to an almost insignificant
level, in contrast to that observed in control set of birds
[5]. Furthermore, the mice (C3H/HeN) when adminis-
tered with MAK 5 (Maharishi Amrit Kalash 5), another
rasayana formulation at concentrations of 50 mg/kg,
100 mg/kg or 200 mg/kg daily per day (3 days /week)
for 2 months showed significant increase in glucose con-
sumption by peritoneal macrophages. Further, the pro-
duction of IFN-gamma and IL-2 was significantly higher
in the rasayana-treated group of animals when compared
to the control group of old mice suggesting that MAK 5
suppressed the age-associated glucose consumption of
peritoneal macrophages and cellular immune function
reduction which, in turn, prevented the immune senes-
cence [38].Conclusion
The study indicates that BR reduced EMS- and MMS-
induced chromosomal aberrations and enhanced the
constitutive base excision repair capacity in mice test
system. The study provides in vivo evidence in mice for
the anticlastogenic activity of BR and hence a potential
for further evaluation in humans on the protective
effects of such formulations in cancer treatments where
patients receive high doses of radiation and chemother-
apy and in anti-ageing research. The components of
Rasayana contribute immensely to the polyherbal’s
observed biological effects. The array of phytochemicals
present within the two major ingredients of BR include
kaempferol, phyllembic acid, corilagin, ellagic acid, lino-
leic acid, pyrogallol, betulinic acid, chebulagic acids and
oleic acid, amongst others [39-43] and may be respon-
sible for the activities observed in this study. The two
major constitutents, Phyllanthus emblica and Termina-
lia chebula have individually shown significant antioxi-
dant activity and preparations containing these two
plants, such as Triphala have shown the same [44].
However the antioxidant potential observed in this
study, using liver tissue, differed from published reports
and may reflect the organ specificity with respect to free
radical scavenging potential, as highlighted above. The
study is limited at present to evidence generated from
studies on mice and further exploration is therefore
required to establish if similar effects are seen in
humans. Further investigations related to the molecular
mechanisms involved in the enhancement of repair are
warranted.
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